151. Radiolabeled hypoxic cell sensitizers: tracers for assessment of ischemia
- Author
-
Dennis W. W. Shaw, Janet S. Rasey, Carla J. Mathias, Paul A Jerabek, Timothy B. Patrick, Marcus E. Raichle, Michael R. Kilbourn, Kenneth A. Krohn, and Michael J. Welch
- Subjects
Male ,Misonidazole ,Pathology ,medicine.medical_specialty ,Ischemia ,Gerbil ,General Biochemistry, Genetics and Molecular Biology ,chemistry.chemical_compound ,In vivo ,medicine ,Animals ,General Pharmacology, Toxicology and Pharmaceutics ,Hypoxia, Brain ,Radioisotopes ,Nitroimidazole ,medicine.diagnostic_test ,Brain ,General Medicine ,Cerebral Infarction ,Fluorine ,medicine.disease ,Arterial occlusion ,chemistry ,Positron emission tomography ,Cerebrovascular Circulation ,Cancer research ,Gerbillinae ,Emission computed tomography - Abstract
Hypoxic, non-functional, but viable, tissue may exist in heart and brain following an arterial occlusion. Identification of such tissue in vivo is crucial to the development of effective treatment strategies. It has been suggested that certain compounds capable of sensitizing hypoxic tumor cells to killing by x-rays (i.e., misonidazole) might serve as in vivo markers of hypoxic tissue in ischemic myocardium or brain if properly radiolabeled. To this end we have radiolabeled two fluorinated analogs of nitroimidazole based hypoxic cell sensitizers with the 110 minute half-lived positron-emitting fluorine-18. The ability of these tracers to quantitate the presence of hypoxic tissue has been studied in a gerbil stroke model. The in vivo uptake of one of these tracers [F-18]-fluoronormethyoxymisonidazole is dependent on the extent of tissue hypoxia, and thus, appears to have potential as a diagnostic indicator of non-functional but viable tissue when the tracer is used in conjunction with positron emission tomography.
- Published
- 1987